CS DIAGNOSTICS CORP. (CSDX)
About CS DIAGNOSTICS CORP.
CS DIAGNOSTICS CORP
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $94.2K
- Net income
- $32.1K
- Total assets
- $499.4M
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
CS Diagnostics Corp. (CSDX) Stock Price
- Profitable — net income of $32.1K in FY2025.
- Trading 82% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review CS DIAGNOSTICS CORP..
Write a review
News about CS DIAGNOSTICS CORP.
News & sentiment via Polygon.io
CS Diagnostics Corp.: frequently asked questions
Is CS Diagnostics Corp. an American company?
CS Diagnostics Corp. is a US-based company, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Is CS Diagnostics Corp. publicly traded?
Yes — CS Diagnostics Corp. is a publicly traded company. Its stock trades under the ticker symbol CSDX on the OTC.
What does CS Diagnostics Corp. do?
CS Diagnostics Corp. is an American Cosmetics company in the Health & Beauty sector.
